This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Aventis Pasteur Limited. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Francois Pelloquin
Introduction
Francois Pelloquin is a notable inventor based in Lyons, France. He has made significant contributions to the field of biotechnology, particularly in the detection of reverse transcriptase activity in eukaryotic cell lines. His work is essential for ensuring the safety of biological products, including viral vaccines.
Latest Patents
Francois Pelloquin holds a patent for the invention titled "CoRT-PCR assay for the discrimination of endogenous reverse transcriptase activity in eukaryotic cell lines from infectious retrovirus contamination." This patent addresses the detection of reverse transcriptase enzymatic activity in eukaryotic cell lines. The invention provides a method to differentiate between endogenous reverse transcriptase activity in substrate cell lines and exogenous infectious retrovirus. By utilizing a combination of transmissibility assays and PBRT assays, the invention allows for the detection of exogenous infectious RT activity while avoiding the detection of endogenous RT activity.
Career Highlights
Francois Pelloquin is associated with Aventis Pasteur Limited, a leading company in the field of vaccines and biological products. His work at the company has been instrumental in advancing methodologies that enhance the safety and efficacy of vaccines.
Collaborations
Francois has collaborated with notable colleagues, including Scott J Goebel and Maurice Harmon. These collaborations have contributed to the development of innovative solutions in the field of biotechnology.
Conclusion
Francois Pelloquin's contributions to the field of biotechnology through his patent and work at Aventis Pasteur Limited highlight his role as an influential inventor. His innovative methods for detecting reverse transcriptase activity are vital for the safety of biological products.